Humanwell Group

About Humanwell Healthcare

Founded in 1993 by a group of passionate college graduates, Humanwell Healthcare has grown into a fully integrated healthcare solutions provider. With headquarters in the center of China, Humanwell operates and serves its customers in over 50 countries and districts. The company’s vision is to be the leader of each market segment it chooses to participate, by providing its customers the highest quality products, the most comprehensive healthcare solutions, at the affordable prices. 

Humanwell is the market leader in anesthetics/analgesics, fertility regulation drugs, and Uyghur medicine in Asia. It is also a major player with expanding product portfolio and market shares in treating central nerve system (CNS), respiratory and dermatological diseases in China.

Humanwell’s core value centers on integrity, equality and humanity. Its mission is to benefit humankind (as it is reflected in the company’s name) by improving human healthcare around the world through our commitments to patients, customers, shareholders and employees. By leveraging our global resources and partnerships, the company strives to challenge the unmet medical needs of every patient and customer around the world.


PuraCap Global

PuraCap Pharmaceuticals LLC is an international pharmaceutical enterprise focusing on the world and engaged in the high-end technology platform. Focusing on building a “world-class pharmaceutical company”, it has established successively PuraCap America, Humanwell Puracap Pharmaceuticals (Wuhan) Co., Ltd., and Humanwell Likang Pharmaceutical. It also has acquired the major American pharmaceutical plant formerly known as Epic Pharma and established PuraCap Caribe and PuraCap Laboratories companies, bringing all of them into the PuraCap pharmaceutical system for operation and management. It is complete with the quality assurance system ranging from global production, packaging to logistics. As an advanced and iconic enterprise of China pharmaceutical internationalization, PuraCap strictly adheres to the GMP management requirements of FDA, ICH, the EU and the CFDA and works to join the ranks of world-class pharmaceutical producers.

  • Humanwell US Company (Humanwell international platform) is an America-based pharmaceutical company which has mature capability on drug R&D, manufacturing and sales.
  • Exploring the China and US markets deeply is the key strategy for the international development of Humanwell;
  • Independently register, commercially acquire and grow our branded, generics, and OTC businesses through our own excellent independent R&D team and first-class production line.
  • Build world’s class branded & prescription drugs production quality standards.